House Regulatory Affairs Subcommittee To Hold Field Hearing In Boston On Oxycontin

Sep 13, 2005
On Tuesday, September 13, at 11:00 AM, Chairman Candice Miller (R-MI) and Ranking Member Stephen F. Lynch (D-MA) of the U.S. House Subcommittee on Regulatory Affairs will hold a Field Hearing on the regulation of Schedule II prescription painkillers like OxyContin.

At the hearing, the Subcommittee will hear testimony from representatives of the U.S. Food and Drug Administration, the Drug Enforcement Agency, the Massachusetts House and Senate, a substance abuse treatment facility and the American Cancer Society.

As a result of the extensive abuse of OxyContin and the federal government’s lack of cohesive oversight policy for this Class II Controlled Substance, Congressman Lynch has introduced legislation that would ban the drug from the market.


WHO:            Chairman Candice Miller (R-MI)

Ranking Member Stephen F. Lynch (D-MA)

                                                Dr. Robert Meyer, Food and Drug Administration

                                                Joseph Rannazzisi, Drug Enforcement Admin.

                                                MA State Senator Steven Tolman

                                                MA State Representative Brian Wallace

                                                John McGahan, Cushing House Executive Director

                                                Dr. Janet L. Abrahm, American Cancer Society


WHAT:          "OxyContin and Beyond: 

Examining the Role of FDA and DEA in

Regulating Prescription Painkillers”


WHEN:          Tuesday, September 13, 2005


TIME:            11:00 AM


WHERE:       Supreme Judicial Court of Suffolk County

                        John Adams Courthouse

                        Oliver Wendell Holmes Courtroom #2

                        1 Pemberton Square, Boston